Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumors × Sunitinib × Clear all

Phase

Phase 1 3 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 8 Kidney Neoplasms 5 Neoplasms 2 Gastrointestinal Stromal Tumors 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Somatostatinoma 1 Solid Tumors 1 Refractory Solid Tumors 1 Neoplasm Metastasis 1 Gastrointestinal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

tivozanib 1 temsirolimus 1 Whey Proteins 1 Sunitinib 1 Paclitaxel 1 Nutrition Assessment 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00798889 2013-01-21

Rollover Protocol for Prior SU011248 Protocols

Pfizer

Phase NA Completed

314 enrolled 6 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡